Literature DB >> 31349749

The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma.

Zhen Zeng1, Jinghui Dong2, Yinyin Li1, Zheng Dong1, Ze Liu1, Jiagan Huang1, Yonggang Wang3, Yunhuan Zhen4, Yinying Lu1.   

Abstract

Long non coding RNAs (lncRNAs) are important in the occurrence and development of various cancers. They have been considered to participate in many processes of diseases. In this study, we aimed at investigating expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma (HCC). The expression of X91348 in tissue and serum samples from patients with HCC and from healthy people was detected through quantitative real-time polymerase chain reaction (qRT-PCR). X91348 expression was decreased in patients with HCC compared with healthy controls no matter in tissue or serum samples. The relationship between X91348 expression and clinicopathologic characteristics was analysed. The result demonstrated that tumour size, HBsAg and Child-Pugh were vital influencing factors for X91348 expression, which revealed X91348 may be involved in the progress of HCC. Kaplan-Meier analysis was used to evaluate overall survival of patients with different expressions of X91348. Finally, prognostic value of X91348 in HCC was assessed via cox regression analysis. X91348 was proved to be closely related to the prognosis of HCC. Taken together, the down-regulation of X91348 could be an independent diagnostic and prognostic indicator for HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; diagnosis; lncRNA X91348; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31349749     DOI: 10.1080/21691401.2019.1640228

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  5 in total

Review 1.  Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies.

Authors:  Barbara Pardini; Alexandru Anton Sabo; Giovanni Birolo; George Adrian Calin
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

Review 2.  The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Bashdar Mahmud Hussen; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-21       Impact factor: 6.244

3.  Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.

Authors:  Yungang Zhu; Baoguo Li; Guoping Xu; Changrui Han; Gang Xing
Journal:  Oncol Rep       Date:  2021-10-11       Impact factor: 3.906

4.  lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma.

Authors:  Siyao Wu; Yayan Deng; Yue Luo; Jiaxiang Ye; Zhihui Liu
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

5.  Lnc-ATG9B-4 aggravates progress of hepatocellular carcinoma through cell proliferation and migration by upregulating CDK5.

Authors:  Ming Li; Le Wei; Pin-Yue Liu; Xue-Mei Zhang; Fang Liu; Fen Yang; Xiang-Shang Hu; Zhong-Cheng Mo
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.